Logotype for Century Therapeutics Inc

Century Therapeutics (IPSC) investor relations material

Century Therapeutics H.C. Wainwright 27th Annual Global Investment Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Century Therapeutics Inc
H.C. Wainwright 27th Annual Global Investment Conference summary5 Sep, 2025

Strategic transformation and pipeline prioritization

  • Over the past six months, a focused transformation has prioritized programs with the highest market potential, optimizing capital and resources.

  • Core pipeline programs are being accelerated, all engineered with proprietary AlloVision technology.

  • Emphasis on both immune and non-immune cell programs, with a non-immune cell candidate nearing drug candidacy.

  • Cash runway extends into Q4 2027, supporting progress beyond key clinical milestones.

Technology platforms and innovation

  • AlloVision technology enables enhanced persistence and re-dosing by providing immune evasion through multiple genetic edits.

  • AlloVision 5.0 incorporates pan-NK inhibitory ligand CD300a and an IgG-degrading protease for broad immune protection.

  • Preclinical data show CD300a taser provides protection across diverse NK cell types, outperforming CD47-based approaches.

  • IgG-degrading enzyme eliminates complement-dependent cytotoxicity and antibody-dependent cellular phagocytosis.

Progress in iPSC-derived T cell therapies

  • Developed iPSC-derived alpha-beta T cells (CD4/CD8) functionally comparable to primary T cells, addressing a major field challenge.

  • Century 308, a CD19-targeted CARiT therapy, shows in vitro and in vivo efficacy, persistence, and tumor control similar to primary CAR T cells.

  • Four-stage differentiation process enables tunable CD4/CD8 T cell mix, essential for effective immunotherapy.

  • Preclinical studies demonstrate robust cytotoxicity, IL-2 secretion, and expansion upon target engagement.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Century Therapeutics earnings date

Logotype for Century Therapeutics Inc
Chardan’s 9th Annual Genetic Medicines Conference21 Oct, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Century Therapeutics earnings date

Logotype for Century Therapeutics Inc
Chardan’s 9th Annual Genetic Medicines Conference21 Oct, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Century Therapeutics Inc. is a biotechnology company focused on developing innovative cell therapy products. The company specializes in the creation of allogeneic cell therapies derived from induced pluripotent stem cells (iPSCs). These therapies are designed to treat a range of conditions, including solid tumors and hematological malignancies. Century Therapeutics' leading product candidates include therapies targeting specific cancer markers, such as CD19 and Nectin-4, and are developed through advanced gene editing and cellular engineering technologies. The company is headquartered in Philadelphia, Pennsylvania, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage